High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
about
Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 proteinIsolation of efficient antivirals: genetic suppressor elements against HIV-1.High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant RevGenetic and functional analysis of HIV-1 Rev Responsive Element (RRE) sequences from North-India.Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.Lentivirus and foamy virus vectors: novel gene therapy tools.Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine.Genetic therapy for HIV/AIDS.Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activityRecent advances in delivery systems for anti-HIV1 therapy.T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependentDevelopment and prospects for bispecific antibody-based therapeutics in cancer and other applications.A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle.An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication.Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replicationScaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells.Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.Targeting tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexes.A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycleLentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap.
P2860
Q30304057-0118F796-1675-4060-80A6-65D673EF9AE5Q30701530-97A4C457-A26D-4608-979D-42135DF027F3Q33784122-F66B0D13-26B8-464F-8F63-740C26B0CBEBQ33851112-A3CA32A6-C446-47B9-942D-A520FB32FBB4Q34060633-18E5A78E-7EC5-4935-8D81-73BAD9F533CFQ34353375-A64E951E-C295-4939-893B-6D4D60436281Q34452109-AAFCD1C7-027D-4AD8-9438-E34EC590BA19Q34657676-9D4A789E-B59D-4130-BB78-20EA6C5DEB34Q35207524-86EC3C95-9CD2-40FE-8B9B-3BB8EF2837F2Q36726945-48A19048-AE0B-4765-8E1B-8035FC5B5F64Q36761854-E052BB53-B6B6-4706-994F-88CD879C25B7Q36842738-38804C83-7C03-481D-A5BD-B307C0C5DF40Q36908573-A7BB099B-B8FF-4C9F-8AF8-C5D85B856F19Q38090680-A068837B-C4B2-47F6-BB02-69CF0F690BFEQ38572657-D85E2853-2864-4544-A892-FE93CC3C2155Q39548149-BFF6229B-2EFC-4836-AA5B-9E66723A7DAAQ39551059-AFDF4D1E-50EE-401B-B4A5-2FA2F967CB19Q39577700-7B325468-9190-45E7-BB47-6C764B5F883CQ39578259-11FD3CF5-4882-43A9-9C42-FA48AEC0B068Q40739621-02C61BA0-2EEC-4FC0-ADC8-4A158C1C01E9Q41973410-55BE445C-2363-4704-9DD8-730BFCB9A17AQ42546287-21585350-ECD1-40DE-91E6-D51EF9F92B1CQ43600028-CA9999CE-0D08-443E-8239-F95C1E72F4E3
P2860
High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@ast
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@en
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@nl
type
label
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@ast
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@en
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@nl
prefLabel
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@ast
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@en
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@nl
P2093
P356
P1433
P1476
High transdominant RevM10 prot ...... tion for gene therapy of AIDS.
@en
P2093
Bonyhadi M
Böhnlein E
Matsuzaki H
P2888
P304
P356
10.1038/SJ.GT.3300369
P577
1997-02-01T00:00:00Z